Merilog will be provided by prefilled pen in a 3 mL dose or in a multiple ... Novo Nordisk announced a planned 75% reduction in the cost of NovoLog. Then a few days later, Sanofi followed suit ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart ... single-patient-use prefilled pen; the prefilled pen dials in ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children with diabetes mellitus. The FDA approved 3 mL single-patient-use prefilled pen and 10 mL ...

Like Novolog, Merilog should be administered within ... According to MSF, data published in JAMA Network Open shows that insulin pens could be produced for as little as $0.94 per unit and remain ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement ... a 3 milliliter single-patient-use prefilled pen and a 10 milliliter multiple-dose vial.

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...